U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07355725) titled 'To Evaluate the Efficacy of Lutemax 2020 on Vision and Cognitive Performance in Health Children.' on Feb. 10, 2023.

Brief Summary: To address the detrimental effects of the sudden rise in the use of digital devices leading to increased screen time, the present study will assess the efficacy of macular carotenoid supplementation Lutemax 2020 in young children

Study Start Date: July 21, 2022

Study Type: INTERVENTIONAL

Condition: Cognitive

Intervention: DIETARY_SUPPLEMENT: Lutemax 2020 gummies

Lutein 10 mg & Zeaxanthin isomers 2 mg

OTHER: Placebo

Placebo gummies

Recruitment Status: COMPLETED

Sponsor: Bioagile Therapeutics Pv...